UNICREDIT BANK/CALL/SANOFI/80/0.1/19.03.25 Share Price

Warrant

DE000HD43C21

Market Closed - Börse Stuttgart 12:12:22 04/07/2024 am IST
1.52 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/SANOFI/80/0.1/19.03.25
Current month+3.40%
1 month+2.01%
Date Price Change
03/24/03 1.52 0.00%
02/24/02 1.52 -7.32%
01/24/01 1.64 +11.56%
28/24/28 1.47 +1.38%
27/24/27 1.45 -7.05%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 12:12 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer UniCredit UniCredit
WKN HD43C2
ISINDE000HD43C21
Date issued 25/03/2024
Strike 80
Maturity 19/03/2025 (259 Days)
Parity 10 : 1
Emission price 1.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.72
Lowest since issue 0.95
Spread 0.01
Spread %0.65%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
90.23 EUR
Average target price
108.1 EUR
Spread / Average Target
+19.79%
Consensus